UPDATE 1-Targacept ends Alzheimer's drug trial after mid-stage failure

July 14 (Reuters) - Targacept Inc said it was ending a mid-stage trial on its Alzheimer's drug as it did not show superiority over standard medication, sending its shares down as much as 19.8 percent.